Road to Commercialization – A CDMO Perspective

[Available On-Demand]
Search General Info
The dynamic of biopharmaceutical industries to bring innovative product to the patients has evolved over the years. Avid Bioservices, as a CDMO with production scales including multiple 2kL SUBs, is an integral part of the supply chain to bring lifesaving drugs to commercialization. Avid has successfully completed 10 late stage cell culture based drug substance manufacturing campaigns for numerous clients. The presentation will focus on the lessons learned from various critical activities (such as process characterization) that supports the success of the “at-scale” process validation program which in turn enables our clients to submit for market approval.

Speaker - Richard Richieri, Chief Operations Officer, Avid Bioservices